CARLE VANESSA

PrivateCIK: 1855763
Location

KELOWNA, A1

CARLE VANESSA (Secretary) purchased 750.00 shares of LEXARIA BIOSCIENCE CORP. on the open market

Open‑market purchase worth $682.50. The strongest form of insider conviction signal.

P · 1 purchase
InsiderCARLE VANESSACIK 1855763
IssuerLEXARIA BIOSCIENCE CORP.CIK 1348362
Officer· Secretary
Since Apr 2021
+750.00
Net shares
Net buyer
$682.50
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
750.00 acquired
Non-Derivative Transactions1

common shares

Direct
P · Purchase

Shares

+750.00

Price / share

$0.91

Trade value

$682.50

% of position

New position
7/29/2025
0.00750.00
Total

Net shares

+750.00

Net value

$682.50

Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)7

Stock Options

Direct
Underlying security
Common Shares

Underlying shares

10K

Shares owned

27.50K

Exercise price

3

Expiration

Exercise window

Stock Options

Direct
Underlying security
Common Shares

Underlying shares

12.50K

Shares owned

40K

Exercise price

2.91

Expiration

Exercise window

Stock Options

Direct
Underlying security
Common Shares

Underlying shares

10K

Shares owned

50K

Exercise price

1.15

Expiration

Exercise window

Stock Options

Direct
Underlying security
Common Shares

Underlying shares

12.50K

Shares owned

12.50K

Exercise price

3

Expiration

Exercise window

Stock Options

Direct
Underlying security
Common Shares

Underlying shares

15K

Shares owned

75K

Exercise price

1.04

Expiration

Exercise window

Stock Options

Direct
Underlying security
Common Shares

Underlying shares

10K

Shares owned

60K

Exercise price

2.36

Expiration

Exercise window

Stock Options

Direct
Underlying security
Common Shares

Underlying shares

5K

Shares owned

17.50K

Exercise price

3

Expiration

Exercise window

Total

Underlying

75K

Owned

282.50K

CARLE VANESSA — Insider Transaction (Form 4) Filed Jul 30, 2025 | Finecho